The Economic Times daily newspaper is available online now.

    Granules India rises 3% on USFDA nod to insomnia drug

    Synopsis

    The company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.

    Pharma-2---PTIPTI
    The scrip has rallied 158 per cent so far this year and 260 per cent in the past one year.
    NEW DELHI: Shares of Granules India climbed 3 per cent in Monday's trade after the drug maker said its US-based subsidiary has received approval for Ramelteon tablets, which is used in the treatment of insomnia.

    The United States Food & Drug Administration (USFDA), it said, has approved the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals Inc for Ramelteon tablets, 8 mg. The product is a generic version of Takeda Pharmaceuticals USA, Inc's Rozerem tablets in the same strength, the company said.

    Following the development, the stock rose 3.11 per cent to hit a high of Rs 324.70 on BSE. With this, the scrip has rallied 158 per cent so far this year and 260 per cent in the past one year. On the technical front, the scrip has been trading above its 5-day, 20-day, 50-day, 100-day and 200-day moving averages.

    According to IQVIA Health data, Ramelteon tablets had US sales of around $33 million moving annual total (MAT) for the 12 months ended June 2020, Granules India said.

    The tablets are used for the treatment of insomnia characterized by difficulty with sleep onset, it added.

    The company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.



    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more


    (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.

    Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

    ...more
    The Economic Times

    Stories you might be interested in